Clinical Trials Directory

Trials / Completed

CompletedNCT05836376

Is Mitral Annuloplasty an Effective Treatment for Severe Atrial Functional MR?

Status
Completed
Phase
Study type
Observational
Enrollment
55 (actual)
Sponsor
Michele De Bonis · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Atrial functional mitral regurgitation (MR) is caused by annular dilatation and flattering associated with altered atria/annulus dynamics in patients with severely dilated left atrium and normal leaflets anatomy. Inadequate leaflets adaption is considered a mechanistic culprit as well. Prevalence of at least moderate atrial functional MR varies between 4.7% and 7% in patients with permanent and long standing persistent atrial fibrillation (AF) and is even higher in patients with Heart Failure with preserved Ejection Fraction (HFpEF). Unlike secondary MR in the setting of left ventricular disease, results of surgical treatment of severe atrial functional MR has remained largely unspoken. The aim of this study is to analyze short and mid-term results of isolated annuloplasty in patients with severe, symptomatic atrial functional MR, in comparission to a matched cohort of patients with secondary MR.

Conditions

Interventions

TypeNameDescription
PROCEDUREMitral valve annuloplastyimplantation of a prosthetic ring to treat mitral valve regurgitation

Timeline

Start date
2020-11-30
Primary completion
2020-12-02
Completion
2020-12-02
First posted
2023-05-01
Last updated
2023-05-01

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05836376. Inclusion in this directory is not an endorsement.